InsiderClue
Insiders · Profile

Price Ben Gil

Director at Opus Genetics · Director at Sarepta Therapeutics. Filing since 15 Aug 2008. CIK 0001417915

IRD Opus Genetics, Inc. Director · 1 trade SRPT Sarepta Therapeutics, Inc. Director · 10 trades
Company
Date
Role
Action
Shares
Amount
Of holding
IRD Opus Genetics, Inc.
29 Jan 2019
Director
Bought
15,000
$9.14K
opened
SRPT Sarepta Therapeutics, Inc.
14 Mar 2016
Director
Bought
4,500
$75.14K
11.7%
SRPT Sarepta Therapeutics, Inc.
19 Aug 2013
Director
Bought
500
$15.59K
1.4%
SRPT Sarepta Therapeutics, Inc.
14 Mar 2012
Director
Bought
30,000
$38.85K
17.9%
SRPT Sarepta Therapeutics, Inc.
6 Apr 2011
Director
Bought
20,000
$30.00K
14.0%
SRPT Sarepta Therapeutics, Inc.
13 Aug 2010
Director
Bought
4,000
$7.72K
4.0%
SRPT Sarepta Therapeutics, Inc.
11 Jun 2010
Director
Bought
7,000
$10.08K
7.6%
SRPT Sarepta Therapeutics, Inc.
13 May 2010
Director
Bought
40,000
$54.40K
46.0%
SRPT Sarepta Therapeutics, Inc.
16 Mar 2009
Director
Bought
20,400
$13.70K
33.1%
SRPT Sarepta Therapeutics, Inc.
13 Mar 2009
Director
Bought
30,000
$19.38K
95.0%
SRPT Sarepta Therapeutics, Inc.
15 Aug 2008
Director
Bought
6,582
$8.03K
26.3%
11 decisions on file.